Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Pluristem, Sosei create Japanese JV

Executive Summary

Pluristem Therapeutics Inc. and Sosei Group Corp.'s venture capital arm Sosei CVC are creating a joint venture to develop and commercialize Pluristem’s PLX-PAD cells in Japan.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Gene Therapy, Cell Therapy
Deal Status
  • Final
Deal Type
  • Alliance
    • Joint Venture
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register